Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2012-11-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Video Documentation of Localized Complications
NCT01453322
A Comprehensive Look at Vascular Access
NCT01638065
Percentage Venous Options in Pediatrics & Adults
NCT01453335
Clinical Verification Evaluation of VeinViewer® Device
NCT01807507
Grade Analysis of Veins by MRI and CT in Post-Thrombotic Syndrome
NCT06451484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VeinViewer
Vascular imaging technology will be used to visualize peripheral vasculature.
VeinViewer
Updated software on the VeinViewer device will be used to project an image of the vasculature on the skin.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VeinViewer
Updated software on the VeinViewer device will be used to project an image of the vasculature on the skin.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Must be considered to be in overall good health by investigator
3. Must pass all prescreening questions
4. Must be able to read and understand English
Exclusion Criteria
2. IV cannulation in the arms or hands in the previous 4 weeks.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Christie Medical Holdings, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory Schears, MD
Role: PRINCIPAL_INVESTIGATOR
Christie Medical Holdings, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christie Medical Holdings, Inc.
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP1019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.